Healthy fats and oils essential to satisfy calorie-conscious consumers

July 21, 2004

Palo Alto, Calf -- July 21, 2004 -- Reacting to the obesity epidemic, food consumers have stirred a global health revolution and are increasingly demanding healthier oils and fats. Since eliminating fats can upset the nutritional balance, researchers are constantly trying to develop innovative methods to improve the health properties of oils and fats.

Though fats and edible oils are largely to blame for obesity and other related health issues, they are integral to a balanced diet and assist in the absorption of fat-soluble vitamins. This is driving the R&D efforts toward reduced fat and lower calorie foods without altering traditional eating habits.

"Fat-based replacers are gradually gaining momentum in the market since they produce fats that eliminate extra calories while retaining the essential fatty acids, as well as the texture and flavor found in traditionally used fats," explain Technical Insights Research Analyst Anil Naidu.

Olestra recently entered the fat substitutes market after resolving health issues surrounding its consumption and gaining approval from the Food and Drug Administration (FDA). Another breakthrough in the search for low-fat palatable foods is the development of fat-free cream cheese with the firmness, flavor, and texture of regular cream cheese.

Since spreads are major sources of dietary fat and extremely popular among consumers, researchers are taking active steps to reduce their fat content by replacing sweeteners with corn syrup. Corn syrup spreads are low in fat and calories and they do not compromise on the flavor.

Peanut butter is also extremely high in calories since about 50 percent of it is oils while the rest is solid nut particles. Partly replacing nut solids with corn syrup solids creates a more healthy spread that has at least 50 percent less fat and 33 percent less calories than regular peanut butter.

Genetically modified organisms (GMOs) have become a controversial issue especially in the European Union. In fact, they have introduced a new "Biotech Label Law" that mandates labeling of food products and animal feed containing more than 0.9 percent of GMOs. However, the increasing acreage of biotech crops worldwide points to the growing acceptance of GM seeds.

"Genetically modified seeds address the concerns pertaining to the amount of linolenic acids and free fatty acids in oils and offer many advantages such as high yield, better product shelf life, and a decreased usage of crop protection chemicals," explains Technical Insights Research Analyst Kasturi Nadkarny.

There is also a growing need to educate consumers regarding saturated or trans-fats. To address this issue, the FDA has announced regulations that enforce mandatory labeling of food products containing trans-fats.

"Labeling laws create a more educated consumer who has the opportunity to turn to healthier alternatives such as olive oil and make informed decisions after considering the inherent risks in certain foods," says Naidu.

The labeling legislations also serve as a wake-up call to the food manufacturers to reexamine and even reformulate their ingredients. It simultaneously offers a good market opportunity for healthy oils and fats, resulting in the search for new or altered processing methods and alternative fats and oils ingredients.

Following this trend, the Agricultural Research Service of the U.S. Department of Agriculture has discovered new breeds of corn to create cooking oils and margarine that lower blood cholesterol. Another new blend of cooking oils has the potential to heighten the metabolic rate in humans, thereby lowering cholesterol level by about 13 percent.

"Margarine spreads containing natural plant sterols are formulated in such a way that they contain less cholesterol-raising saturated fat and more cholesterol-reducing polyunsaturated fat and could also reduce cholesterol almost up to 10 percent within three weeks," concludes Nadkarny.
-end-
Edible Oils and Fats: A Global Overview of Technological Developments, part of the Oleochemicals, Surfactants and Specialty Chemicals Industry Vertical Subscription Service, provides a comprehensive analysis of emerging technological developments in the manufacture of edible oils and fats. It analyzes key technical challenges and drivers influencing growth and provides in-depth examination of cutting-edge developments. Executive summaries and interviews are available to the press.

If you are interested in an analysis overview which provide manufacturers, end-users and other industry participants an overview, summary, challenges and latest coverage of Edible Oils and Fats: A Global Overview of Technological Developments - then send an email to Julia Paulson - North American Corporate Communications at jpaulson@frost.com with the following information: Full name, Company Name, Title, Contact Tel Number, Contact Fax Number, Email. Upon receipt of the above information, an overview will be emailed to you.

Technical Insights is an international technology analysis business that produces a variety of technical news alert, newsletter, and report services.

Frost & Sullivan, an international growth consultancy, has been supporting clients' expansion for more than four decades. Our market expertise covers a broad spectrum of industries, while our portfolio of advisory competencies includes custom strategic consulting, market intelligence, and management training. Our mission is to forge partnerships with our clients' management teams to deliver market insights and to create value and drive growth through innovative approaches. Frost & Sullivan's network of consultants, industry experts, corporate trainers, and support staff spans the globe with offices in every major country.

Edible Oils and Fats: A Global Overview of Technological Developments
D291

Contact:
Julia Paulson
Corporate Communications - North America
P: 210-247-3870
F: 210-348-1003
E: jpaulson@frost.com

Katja Feick
Corporate Communications - Europe
P: 44-207-915-7856
F: 44-207-730-3343
E: katja.feick@frost.com

Pramila Gurtoo
Corporate Communications - Asia Pacific
DID : 603-6204-5811
Gen : 603-6204-5800
Fax : 603-6201-7402
E: pgurtoo@frost.com

www.frost.com
www.technicalinsights.frost.com

Keywords in this release: edible oils, fats, fat-based replacers, fatty acids, olestra, fat-free cream cheese, dietary fat, corn syrup, peanut butter, margarine, Agricultural Research Service, U.S. Department of Agriculture, labeling laws, Food and Drug Administration, FDA, cholesterol, olive oil, plant sterols, polyunsaturated fat, saturated fat, trans-fat

Technical Insights

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.